We analyzed the correlations of PBK/TOPK expression with the infiltrating immune cells that exert tumor-killing effect (CD8+, NK cell) and promote tumor immune escape (M2 macrophage, Tregs, CAFs, MDSCs) based on TIMER2.0 to further explore the potential role of PBK in cancer immunity. Here, CD8A is linked to cancer.